ONMD logo

ONEMEDNET CORP

ONMDNASDAQ
๐Ÿ† #3471 by market capUS Equity
$0.74โ–ฒ $0.09 (+12.70%)
๐ŸŒ™ After hours$0.73โ–ผ 2.31%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 12.7%
7dโ–ฒ 16.0%
14dโ–ฒ 17.4%
30dโ–ผ 2.1%
1yโ–ฒ 62.0%
๐ŸฆMarket Cap
$42M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+147.9%
High Growth
๐Ÿ“ŠGross Margin
-51.4%
Thin
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
28.5x
Expensive
Otter Score
47
Weak

Trading Snapshot

Day Range
$0.73 โ€“ $0.75
52-Week Range
$0.44 โ€“ $4.22
Volume
$2.44B
Avg Volume
$2.29B
Shares Outstanding
57.0M
Next Earnings
Oct 27, 2026

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$96,000
P/E Ratio
โ€”
P/S Ratio
28.5x
EPS (TTM)
$-0.04
Dividend Yield
โ€”

Why Investors Own ONMD

  • โœ“High-growth profile โ€” revenue up +58.1% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 58% gross margin and 8% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1Mโ–ฒ +59.4% YoY
Gross Margin (TTM)
57.8%โ–ฒ +1.0% YoY
Operating Income (TTM)
$180,747โ–ฒ +59.4% YoY
Free Cash Flow (TTM)
$108,720โ–ฒ +59.4% YoY

About ONEMEDNET CORP

OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
47/100

Analyst Price Target

โ“˜
Average Target
$0.93
โ–ฒ +25.1% Upside
High Target$1.01
Low Target$0.73
Based on 20 analysts

Latest News & Updates